Evolva Holding SA
SIX:EVE

Watchlist Manager
Evolva Holding SA Logo
Evolva Holding SA
SIX:EVE
Watchlist
Price: 0.92 CHF 9%
Market Cap: CHf6.7m

Evolva Holding SA
Note Receivable

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Evolva Holding SA
Note Receivable Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Note Receivable CAGR 3Y CAGR 5Y CAGR 10Y
Evolva Holding SA
SIX:EVE
Note Receivable
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Sika AG
F:SIKA
Note Receivable
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Givaudan SA
SIX:GIVN
Note Receivable
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Ems Chemie Holding AG
SIX:EMSN
Note Receivable
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Dottikon Es Holding AG
SIX:DESN
Note Receivable
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
D
DSM-Firmenich AG
AEX:DSFIR
Note Receivable
€167m
CAGR 3-Years
1%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Evolva Holding SA
Glance View

Market Cap
6.7m CHF
Industry
Chemicals

Evolva Holding SA is a biotech company, which engages in the research, development, manufacture, and commercialization of nutritional, healthcare, and wellness ingredients. The company is headquartered in Reinach, Basel-Landschaft and currently employs 68 full-time employees. The company went IPO on 2005-05-04. The activity of the Company is divided into two segments: technololgy platforms - combines biology with technology to produce nature-based ingredients; technology servises- provides tailored services to clients across industries. The firm is focused on developing and increase the yield and efficiency of the production of various ingredients.

EVE Intrinsic Value
0.27 CHF
Overvaluation 70%
Intrinsic Value
Price CHf0.92

See Also

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett